DK1799214T3 - Ikke-peptid-bradykinin-antagonister og famaceutiske sammensætninger heraf - Google Patents

Ikke-peptid-bradykinin-antagonister og famaceutiske sammensætninger heraf

Info

Publication number
DK1799214T3
DK1799214T3 DK05789989T DK05789989T DK1799214T3 DK 1799214 T3 DK1799214 T3 DK 1799214T3 DK 05789989 T DK05789989 T DK 05789989T DK 05789989 T DK05789989 T DK 05789989T DK 1799214 T3 DK1799214 T3 DK 1799214T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
bradykinin antagonists
peptide bradykinin
peptide
antagonists
Prior art date
Application number
DK05789989T
Other languages
Danish (da)
English (en)
Inventor
Patrizia Felicetti
Christopher Ingo Fincham
Alessandro Giolitti
Carlo Alberto Maggi
Laura Quartara
Cristina Rossi
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Application granted granted Critical
Publication of DK1799214T3 publication Critical patent/DK1799214T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK05789989T 2004-10-15 2005-09-27 Ikke-peptid-bradykinin-antagonister og famaceutiske sammensætninger heraf DK1799214T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001963A ITMI20041963A1 (it) 2004-10-15 2004-10-15 "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
PCT/EP2005/010412 WO2006040004A1 (en) 2004-10-15 2005-09-27 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom

Publications (1)

Publication Number Publication Date
DK1799214T3 true DK1799214T3 (da) 2008-05-13

Family

ID=35810869

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05789989T DK1799214T3 (da) 2004-10-15 2005-09-27 Ikke-peptid-bradykinin-antagonister og famaceutiske sammensætninger heraf

Country Status (30)

Country Link
US (1) US7645759B2 (it)
EP (1) EP1799214B8 (it)
JP (1) JP4980917B2 (it)
CN (1) CN101039671B (it)
AR (1) AR051392A1 (it)
AT (1) ATE381931T1 (it)
AU (1) AU2005293881B2 (it)
BR (1) BRPI0515983A (it)
CA (1) CA2583920C (it)
CY (1) CY1107254T1 (it)
DE (1) DE602005004039T2 (it)
DK (1) DK1799214T3 (it)
EA (1) EA010913B1 (it)
ES (1) ES2299090T3 (it)
GE (1) GEP20115322B (it)
HK (1) HK1107263A1 (it)
HR (1) HRP20080107T3 (it)
IL (1) IL182494A (it)
IT (1) ITMI20041963A1 (it)
MA (1) MA29007B1 (it)
MX (1) MX2007004297A (it)
NO (1) NO339805B1 (it)
NZ (1) NZ554469A (it)
PL (1) PL1799214T3 (it)
PT (1) PT1799214E (it)
RS (1) RS50563B (it)
SI (1) SI1799214T1 (it)
UA (1) UA86091C2 (it)
WO (1) WO2006040004A1 (it)
ZA (1) ZA200703009B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
WO2008046573A1 (de) 2006-10-16 2008-04-24 Grünenthal GmbH Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
ITMI20072225A1 (it) * 2007-11-23 2009-05-24 Luso Farmaco Inst "composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso"
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
WO2015155323A1 (en) * 2014-04-10 2015-10-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Br2 antagonist for use in the prevention of the hypotensive effect of patient treated with angiotensin-converting enzyme inhibitors (acei)
KR102464380B1 (ko) * 2016-09-16 2022-11-07 다케다 파머수티컬 컴패니 리미티드 접촉 활성화 시스템과 연관된 질환을 위한 대사물질 바이오마커
MA50804B1 (fr) 2017-11-24 2022-05-31 Pharvaris Netherlands B V Nouveaux antagonistes des récepteurs de bradykinine b2
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina
WO2023180575A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction

Also Published As

Publication number Publication date
AU2005293881B2 (en) 2010-02-25
WO2006040004A1 (en) 2006-04-20
CN101039671A (zh) 2007-09-19
BRPI0515983A (pt) 2008-08-12
MA29007B1 (fr) 2007-11-01
NO339805B1 (no) 2017-02-06
PT1799214E (pt) 2008-03-31
IL182494A0 (en) 2007-09-20
EP1799214A1 (en) 2007-06-27
JP2008516901A (ja) 2008-05-22
US7645759B2 (en) 2010-01-12
CA2583920C (en) 2013-02-12
ZA200703009B (en) 2008-08-27
ITMI20041963A1 (it) 2005-01-15
NZ554469A (en) 2010-02-26
EA010913B1 (ru) 2008-12-30
HRP20080107T3 (en) 2008-05-31
JP4980917B2 (ja) 2012-07-18
ES2299090T3 (es) 2008-05-16
ATE381931T1 (de) 2008-01-15
US20070281944A1 (en) 2007-12-06
HK1107263A1 (en) 2008-04-03
CN101039671B (zh) 2010-10-13
GEP20115322B (en) 2011-11-10
NO20071840L (no) 2007-04-11
DE602005004039T2 (de) 2009-01-22
PL1799214T3 (pl) 2008-05-30
DE602005004039D1 (de) 2008-02-07
CA2583920A1 (en) 2006-04-20
EP1799214B8 (en) 2008-06-18
SI1799214T1 (sl) 2008-06-30
EP1799214B1 (en) 2007-12-26
MX2007004297A (es) 2008-03-11
IL182494A (en) 2011-07-31
EA200700584A1 (ru) 2007-10-26
AU2005293881A1 (en) 2006-04-20
UA86091C2 (ru) 2009-03-25
RS50563B (sr) 2010-05-07
AR051392A1 (es) 2007-01-10
CY1107254T1 (el) 2012-11-21

Similar Documents

Publication Publication Date Title
DK1799214T3 (da) Ikke-peptid-bradykinin-antagonister og famaceutiske sammensætninger heraf
BRPI0511900A (pt) composições farmacêuticas
DK1753406T4 (da) Overtrukket tabletformulering og fremgangsmåde
NO20081604L (no) Nitrogeninneholdende heterocyklisk forbindelse og farmasøytisk anvendelse derav
DK3437682T3 (da) Lægemiddeladministrationsanordning
PL1861387T3 (pl) Pochodne benzoimidazolu i ich kompozycje farmaceutyczne
ATE434623T1 (de) Interleukin-15-antagonistisches peptid
DK1513531T3 (da) Basisk non-peptide bradykinin antagonister og farmaceutiske sammensætninger deraf
DK1957073T3 (da) Lægemiddel
DK1808446T3 (da) IL-18-receptor-antagonist og farmaceutisk sammensætning indeholdende antagonisten
DE602006003063D1 (de) Tripeptid- und tetrapeptidsulfone
DK1968990T3 (da) Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
PT1861387E (pt) Derivados de benzimidazol e composições farmacêuticas dos mesmos
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
ATE397618T1 (de) Peptidcyclisierung
DE602005012674D1 (de) Nachweiselement und nachweisverfahren
DK2474528T3 (da) Antineoplastiske forbindelser og farmaceutiske kompositioner deraf
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
SE0402639D0 (sv) Pharmaceutical use
SE0402678D0 (sv) Pharmaceutical use
SE0402637D0 (sv) Pharmaceutical use
SE0402638D0 (sv) Pharmaceutical use
UA10045S (uk) Піктограма фармацевтичного засобу (в таблетках)
UA10369S (uk) Таблетка фармацевтична